File size: 14,400 Bytes
7694c07 | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 | \begin{table}[h!] \begin{adjustbox}{max width=1.2\textwidth} \begin{threeparttable} \caption{Descriptive Statistics from Control Group} \label{control_group} { \begin{tabular}{l*{6}{c}} \hline\hline & \multicolumn{1}{c}{(1)} & \multicolumn{1}{c}{(2)} & \multicolumn{1}{c}{(3)} & \multicolumn{1}{c}{(4)} & \multicolumn{1}{c}{(5)} \\ & \multicolumn{2}{c}{Full Sample} & \multicolumn{3}{c}{Has Valid RDT (Home Survey)} & \\ \cmidrule(lr){2-3} \cmidrule(lr){4-6} & \multicolumn{1}{c}{\shortstack{N}} & \multicolumn{1}{c}{\shortstack{Mean}} & \multicolumn{1}{c}{\shortstack{All\\Patients}} & \multicolumn{1}{c}{\shortstack{RDT\\Positive}} & \multicolumn{1}{c}{\shortstack{RDT\\Negative}} \\ \hline
\emph{Panel A. Malaria Beliefs and Treatment Outcomes} & \\
\enspace Respondent Suspects Illness is Malaria (Pre-Consultation) & 628& 0.551& 0.610& 0.791& 0.550&\\
\enspace Simple Malaria Treatment: Prescribed & 627& 0.313& 0.295& 0.163& 0.338&\\
\enspace Simple Malaria Treatment: Purchased & 627& 0.206& 0.197& 0.140& 0.215&\\
\enspace Severe Malaria Treatment: Prescribed & 627& 0.303& 0.327& 0.593& 0.238&\\
\enspace Severe Malaria Treatment: Purchased & 627& 0.255& 0.283& 0.535& 0.200&\\
\emph{Panel B. Other Treatment Outcomes} & \\
\enspace Purchased Antibiotics & 627& 0.426& 0.442& 0.430& 0.446&\\
\enspace Received Injection or IV & 628& 0.398& 0.454& 0.674& 0.381&\\
\enspace Patient Referred to Hospital or Placed Under Observation & 628& 0.139& 0.179& 0.395& 0.108&\\
\emph{Panel C. Patient Costs} & \\
\enspace Total Cost No Malaria Treatment (CFA) & 301& 2793.349& -- & -- & -- &\\
\enspace Total Cost Simple Malaria (CFA) & 126& 4474.873& -- & -- & -- &\\
\enspace Total Cost Severe Malaria (CFA) & 147& 10352.714& -- & -- & -- &\\
\hline \end{tabular} } \begin{tablenotes}[flushleft] \small \item \emph{Notes}: Column 1 reports the number of non-missing observations of variables among all individuals in the Control group. Column 2 reports means for this sample. Columns 3-6 limit the sample to Control group individuals who were administered a valid RDT test at home, with column 3 reporting means for all patients with a valid test, column 4 reporting means for patients with a positive test, and column 5 reporting means for patients with a negative test. Sample sizes for columns 3, 4, and 5 are 346, 86, and 260 respectively. Variables measured in CFA top-coded at the 99th percentile. CFA610 $\approx$ USD1. \end{tablenotes} \end{threeparttable} \end{adjustbox} \end{table}
|